<?xml version='1.0' encoding='utf-8'?>
<document id="31532898"><sentence text="Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study." /><sentence text="Widespread access to antiretroviral therapy (ART) has substantially increased life expectancy in sub-Saharan African countries" /><sentence text=" As a result, the rates of comorbidities and use of co-medications among people living with HIV are increasing, necessitating a sound understanding of drug-drug interactions (DDIs)" /><sentence text=" We aimed to assess the prevalence and management of DDIs with ART in a rural Tanzanian setting" /><sentence text="" /><sentence text="We included consenting HIV-positive adults initiating ART in the Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) between January 2013 and December 2016" /><sentence text=" DDIs were classified using www" /><sentence text="hiv-druginteractions" /><sentence text="org as red (contra-indicated), amber (potential clinical relevance requiring dosage adjustment/monitoring), yellow (weak clinical significance unlikely to require further management) or green (no interaction)" /><sentence text=" We assessed management of amber DDIs by evaluating monitoring of laboratory or clinical parameters, or changes in drug dosages" /><sentence text="" /><sentence text="Of 2069 participants, 1945 (94%) were prescribed at least one co-medication during a median follow-up of 1" /><sentence text="8 years" /><sentence text=" Of these, 645 (33%) had at least one potentially clinically relevant DDI, with the highest grade being red in nine (&lt; 1%) and amber in 636 (33%) participants" /><sentence text=" Of the 23 283 prescriptions, 19 (&lt; 1%) and 1745 (7%) were classified as red and amber DDIs, respectively" /><sentence text=" Overall, 351 (2%) prescriptions were red DDIs or not appropriately managed amber DDIs" /><sentence text="" /><sentence text="Co-medication use was common in this rural sub-Saharan cohort" /><sentence text=" A third of participants had DDIs requiring further management" /><sentence text=" Of the 9% of participants with not appropriately managed DDIs, most were with cardiovascular and analgesic drugs" /><sentence text=" This highlights the importance of physicians' awareness of DDIs for their recognition and management" /><sentence text="" /></document>